Clinical Trial Update: Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL) [Phase 1, Phase 2]

View source ↗

Summary

This update describes results from a Phase 1/2 study of azacitidine in combination with vorinostat for relapsed or refractory diffuse large B-cell lymphoma (DLB…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• AZACITIDINE (AZACITIDINE)
• Vorinostat (vorinostat)

Snippet

Sponsor: Weill Medical College of Cornell University | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-04-10